HopeStage
Back to all studies
CompletedNCT03233867

Genetic Variants in Children and Adolescents With ADHD

About this title

Read the official source —
Observational studyAges 6–17United States
The study in practice

Understand this study

Who was this study for?

Listed age limits: 6 years to 17 years.

Study clarity

Study information

Study start dateStarted: August 14, 2017
Recruitment status
Completed
Enrollment listed in the registry
2,503
Sponsor
Aevi Genomic Medicine, LLC, a Cerecor company
Sponsor type
Pharmaceutical company
Study type
Observational
Intervention type
Interview / survey / observational
Study phase
Not clearly listed
Locations
United States
Age range
From 6 Years to 17 Years
Official registry ID
NCT03233867
Official title
Show the full official title

A Non-interventional Study to Identify Children and Adolescents (Ages 6-17 Years) With Attention Deficit Hyperactivity Disorder and With or Without Copy Number Variants in Specific Genes Involved in Glutamatergic Signaling and Neuronal Connectivity

Looking for a study you can join?

Explore recruiting studies

Get this study by email

HopeStage may email me about this study.
Loading the security check...

Recruitment & locations

Completed

Wayne

FAQ

Questions about this study

Who is behind this study?

The study sponsor is Aevi Genomic Medicine, LLC, a Cerecor company, a pharmaceutical company.

Who was this study for?

Listed age limits: 6 years to 17 years.

Want to explore more studies?

Explore studies